C2i Genomics vs PreSee
C2i Genomics vs PreSee, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: C2i Genomics is on 62/100 and PreSee on 43/100.
Where each one leads
C2i Genomics
- our overall score: 62/100 against 43/100
- agent readiness: 30/100 against 22/100
- domain rating: 63/100 against 1/100
- headcount: 17 against 1
- funding raised: $112M against $1.5M
PreSee
Leads on none of the measures we hold for both companies.
At a glance
| Measure | C2i Genomics | PreSee |
|---|---|---|
| What it is | Comprehensive whole-genome monitoring for cancer recurrence and progression. | Corporate wellness platform offering advanced medical screening tests in the workplace. |
| Category | Healthcare, Genomics, Cancer, Tumor Detection | Healthcare, Cancer Screening, HealthTech, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2018 | 2020 |
| Headquarters | Tel Aviv, Israel | New York, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | C2i Genomics | PreSee |
|---|---|---|
| Employees | 17 | 1 |
| Headcount growthLast 12 months | -20.8% | Not published |
| Total funding | $112M | $1.5M |
| Latest round | Series B | Seed |
| LinkedIn followers | 6,366 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | C2i Genomics | PreSee |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 43/100 |
| Traction | 53/100 | 34/100 |
| Team | 90/100 | 70/100 |
| Search visibility | 35/100 | 16/100 |
| Quality | 65/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 1/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | C2i Genomics | PreSee |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
C2i Genomics vs PreSee: common questions
Which is better, C2i Genomics or PreSee?
On our 0-100 score C2i Genomics rates higher (62/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do C2i Genomics and PreSee compare on the numbers?
C2i Genomics leads on our overall score (62/100 against 43/100), agent readiness (30/100 against 22/100), domain rating (63/100 against 1/100), headcount (17 against 1), funding raised ($112M against $1.5M).
Read the full C2i Genomics review and pricing or the PreSee review and pricing. You can also browse other C2i Genomics alternatives we track.